Celprogen是一家生物技术公司，为心脏病学、肿瘤学、糖尿病和神经病学的再生医学研发干细胞研究和治疗产品。Celprogen的所有生物产品，包括干细胞、癌症干细胞、IPC和包括ECM在内的培养基，均在美国制造和生产。

CELPROGEN is a biotechnology company developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media including ECM’s, are manufactured and produced in the United States of America. CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, Invitro diagnostics and academic partnership for drug discovery.

Celprogen公司的主要产品：

3D Culture Systems

Biological Reagents

Cell-Based Assay Kits

Cosmetic

Devices

ExtracellularMatrix

Human Serum Albumin (HSA)

Life Science

Normal Cells

Organ Cultures

Patient-Derived Xenografts [PDX]

Therapeutics

Tumorgenicity

Vaccine Development

Xeno-Free Media

AdipoGen Lifesciences 位于美国和瑞士，并在全球遍布分销网络。该公司主要专注于生产最新型的炎症反应、免疫应答和免疫代谢研究方面的产品。产品类型涵盖抗体、生物化学品、细胞系、酶联免疫吸附试验试剂盒、天然产物、蛋白质及其它生化试剂。

AdipoGen is a manufacturer of Products for Advanced Inflammation, Immune Response & Immunometabolic Research. Product include Antibodies, Assays, Biochemicals, Cell Lines, ELISA KITS, Natural Products, Proteins, Other Reagents, Cancer, Immunology, Inflammation, Metabolism, Services and so on.

主要研究方向

（1）炎症；

（2）免疫：天然免疫、自然杀伤性T细胞（NKT细胞）、T细胞生物学、感染；

（3）肿瘤研究：细胞死亡研究、药物抗性、生物标记物、血管新生；

（4）代谢：糖尿病、肥胖症、脂肪因子、动脉粥样硬化性心血管疾病、线粒体功能障碍。

具体产品类型：

Notch信号通道（Notch受体& Notch配体）、内脏脂肪素（Nampt/PBEF）、颗粒蛋白前体、脂联素（ACRP30）、视黄醇结合蛋白4（RBP4）、白介素/炎症研究（IL33/IL17A）、Vaspin、ANGPTLs家族、FGF家族、脂肪因子其他产品（抵抗素/网膜素……）

作为全球血栓与止血诊断领域的领导者，Stago公司的使命是为实验室人员及临床医生提供可靠准确的血栓与止血疾病诊断工具，从而更有效地认知、治疗和监测相关疾病，改善患者生活。

From Research & Development and Production to Logistics, Marketing, Sales and International Distribution, Stago remains in control of its strategy at all levels. Certified ISO 13485, ISO 9001 (2008) and ISO 14001 for its main reagent manufacturing plant. the group’s industrial activities are mostly concentrated in France. Its geographical expansion has led to opening R&D and production centers in the USA, Netherlands, Germany, Ireland and China.  

Ever since our American subsidiary was established in 1985, our distribution network grew considerably throughout the world. Since 2003, 17 new affiliates have been opened: China (2003), United Kingdom (2005), Dubai (2007), Australia/New Zealand and Canada (2008), Hong-Kong (2011), Germany, Austria, Spain, Italy, Portugal, Switzerland, Belgium, Netherlands (all opened in 2012), India (2014), Brazil (2016) and Turkey (2017).

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com